GLP-1 (Glucagon-like peptide-1) Agonists are drugs that imitate a natural hormone in your body to assist in regulating blood sugar levels and appetite
The platform does not employ healthcare providers and does not directly prescribe or dispense medication
This narrative review provides a comprehensive overview of the diverse modeling approaches, critically evaluating their strengths and limitations
This is a trend weve been seeing and its been seen by other studies as well that theres a shortage of these medications because its a much broader indication now than just diabetics its patients who are obese and dont have diabetes can get these medications, he told us
[1] This extended half-life allows for convenient weekly dosing while maintaining stable blood glucose control and appetite suppression throughout the week
However, eligible individuals typically have a BMI of 30 or higher, or a BMI of 27 or higher, along with associated weight-related conditions such as type 2 diabetes, hypertension, or others